Clinical trial
Study of Quality of Life in Patients With Metastatic Breast Cancer Treated With Second-line Monochemotherapy
NCT02403869 is registered in ClinicalTrials.gov with Celgene as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study of Quality of Life in Patients With Metastatic Breast Cancer Treated With Second-line Monochemotherapy
- Lead sponsor
- Celgene
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 12, 2014
- Completion date
- January 31, 2019
- Enrollment
- 149 (actual)
- Sites
- 29
Conditions
As the registry lists them; a condition with its own page is linked.